REGARDS与JHS队列中与缺血性脑卒中发病相关的核苷
在REGARDS队列中开展卒中病例-队列观察性研究,比较1,075例卒中病例与968例随机对照的基线血浆162种代谢物,发现鸟苷(HR 1.34)和假尿苷(HR 1.28)独立关联缺血性脑卒中,遗传与中介分析提示环境暴露而非遗传变异介导该关联,JHS队列部分验证。
要点
- 鸟苷与假尿苷独立于传统危险因素关联缺血性脑卒中发病。
- 鸟苷部分介导高血压与卒中的关系(17.6%),假尿苷未介导任何危险因素。
- 遗传变异未解释假尿苷与卒中的关联,提示环境暴露作用。
核心结论
- 鸟苷和假尿苷与其他危险因素无关地关联缺血性脑卒中发病。
- 遗传与中介分析提示环境暴露而非遗传变异将核苷水平与卒中风险联系起来。
研究设计与样本
- REGARDS队列内嵌套的卒中病例-队列观察性研究,基线血浆用液相色谱-串联质谱测定162种代谢物。
- 共2,043名参与者,平均随访7.1年,包括1,075例卒中病例和968例随机对照。
- Cox比例风险模型基础模型调整年龄、性别、种族及年龄与种族交互,完全调整模型纳入传统卒中危险因素。
- 对卒中危险因素以代谢物为中介进行中介分析,用芯片数据计算候选代谢物的全基因组关联。
- 在Jackson心脏研究(JHS)中用随机效应Meta分析进行重复分析。
主要发现
- 基础模型中有9种代谢物与卒中相关,其中8种在JHS Meta分析中仍显著。
- REGARDS完全调整模型中,经Bonferroni校正后鸟苷(HR 1.34,95%CI 1.18-1.53;P=7.26×10⁻⁶)和假尿苷(HR 1.28,95%CI 1.13-1.45;P=1.03×10⁻⁴)与缺血性脑卒中发病相关。
- 鸟苷部分介导高血压与卒中的关系(17.6%),假尿苷未介导任何危险因素。
- 全基因组关联分析发现rs34631560与假尿苷相关,但未解释假尿苷与卒中的关联。
关键数值与推荐
- 鸟苷完全调整模型HR 1.34(95%CI 1.18-1.53;P=7.26×10⁻⁶)。
- 假尿苷完全调整模型HR 1.28(95%CI 1.13-1.45;P=1.03×10⁻⁴)。
- 鸟苷对高血压与卒中关系的中介比例为17.6%。
- 本研究提供Class II证据表明鸟苷和假尿苷与卒中发病相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Both genetic and environmental factors contribute to stroke risk. We sought to identify novel metabolites associated with incident stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort and determine whether they reflected genetic or environmental variation. METHODS: This was a stroke case-cohort observational study nested in REGARDS. Cases were defined as incident stroke and metabolomic profiles were compared to a randomly selected control cohort. In baseline plasma samples, 162 metabolites were measured using liquid chromatography-tandem mass spectrometry. Cox proportional hazards models were adjusted for age, sex, race, and age by race in the base model. Fully adjusted models included traditional stroke risk factors. Mediation analyses conducted for these stroke risk factors used the metabolite as mediator. Genome-wide associations with the leading candidate metabolites were calculated using array data. Replication analyses in the Jackson Heart Study (JHS) were conducted using random effects meta-analysis. RESULTS: There were 2,043 participants who were followed over an average period of 7.1 years, including 1,075 stroke cases and 968 random controls. Nine metabolites were associated with stroke in the base model, 8 of which were measured and remained significant in meta-analysis with JHS. In the fully adjusted model in REGARDS, guanosine (hazard ratio [HR] 1.34, 95% CI 1.18-1.53; p = 7.26 × 10-6) and pseudouridine (HR 1.28, 95% CI 1.13-1.45; p = 1.03 × 10-4) were associated with incident ischemic stroke following Bonferroni adjustment. Guanosine also partially mediated the relationship between hypertension and stroke (17.6%) and pseudouridine did not mediate any risk factor. Genome-wide association analysis identified loci rs34631560 and rs34631560 associated with pseudouridine, but these did not explain the association of pseudouridine with stroke. DISCUSSION: Guanosine and pseudouridine are nucleosides associated with incident ischemic stroke independently of other risk factors. Genetic and mediation analyses suggest that environmental exposures rather than genetic variation link nucleoside levels to stroke risk. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that guanosine and pseudouridine are associated with incident stroke.
引用
- Ament Z, Patki A, Chaudhary N, et al. Nucleosides Associated With Incident Ischemic Stroke in the REGARDS and JHS Cohorts. Neurology. 2022. PMID: 35264422. doi:10.1212/WNL.0000000000200262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。